SUMMARY In an observer blind comparative study, 130 men with penile warts were randomly allocated to treatment with either cryotherapy or trichloroacetic acid (TCAA). There was no significant difference in response to treatment, side effects, or recurrence rates between the two treatments. Warts resolved in 81% of patients treated with TCAA compared with 88% of those treated with cryotherapy. Early recurrence occurred in 36% of patients treated with TCAA and in 39% of those treated with cryotherapy.
Patients and methods
Heterosexual men with penile warts attending the department of genitourinary medicine at St Thomas' Hospital from May 1983 to July 1985 were invited to join the study. They were excluded if they had been treated for warts in the previous eight weeks, if they had warts at sites other than the penile shaft, prepuce, or glans, or if intrameatal warts were present.
At the first visit all patients were screened for other sexually transmitted disease (STD), as described elsewhere.5 Sexual partners were seen and examined for genital warts and other sexually transmitted disease, and treated as necessary. Patients were advised to use condoms during the period of treatment and follow up.
Patients were randomly allocated to treatment by local application of TCAA or cryotherapy. TCAA was applied to the wart with an orange stick to avoid the surrounding skin. Starch talc was then applied to prevent contamination of adjacent skin. Cryotherapy consisted of liquid nitrogen applied to the wart using The patients were reviewed at weekly intervals by an independent observer who had no knowledge of the treatment given. Treatment was repeated each week until the warts had completely disappeared. If they had not disappeared after 10 treatments, treatment failure was recorded and the alternative treatment was offered.
All patients who had been successfully treated were recalled two months after the end of treatment and examined for the presence of warts.
STATISTICAL METHODS
The time for complete regression of each patient's warts was compared between the two treatment groups. As warts were still present at the end of the treatment period in some patients, the comparison was made using a life table approach. The significance of differences was calculated using a log rank test.6 As some patients attended irregularly for treatment, the analysis was repeated using the number of treatments instead of duration.
Results
Of 130 men who entered the study, 23 failed to attend regularly and were withdrawn. One patient treated with cryotherapy was withdrawn because of severe side effects. Of 69 patients treated with TCAA, 57 (85%) completed the study compared with 49 of 61 (80%) treated with cryotherapy. The characteristics of patients in each treatment group who completed 390 Cryotherapy compared with trichloroacetic acid in treating genital warts Side effects (local discomfort, ulceration, and scab formation) were more common with TCAA, but the difference was not significant. The one patient with- 392 drawn from the study because of severe local discomfort with swelling, blistering, and ulceration had been treated with cryotherapy.
Discussion
These findings indicate that cryotherapy offers little benefit over TCAA in the treatment of genital warts.
Response to treatment was faster with cryotherapy than with TCAA and side effects were less common, but the differences were not significant. Recurrence rates were high with both treatments. The multiplicity of methods that have been used for the treatment of genital warts7 suggests that none is particularly effective. Treatment is often prolonged and time consuming, and recurrence is common. Patient compliance may be difficult to maintain, and treatment failure or relapse may be difficult to distinguish from reinfection. The end point of treatment may be difficult to define as resolving or early warts, scar tissue, and physiological skin blemishes may be indistinguishable from each other. For all these reasons few comparative trials have been reported, and comparisons between different studies are difficult as recommended regimens vary in frequency, amount, and duration of treatment.
Effective treatment is essential for the increasing numbers of patients with genital warts, especially in view of the malignant potential of certain types of the causative human papilloma virus (HPV).8 There seems to be no prospect of an antiviral agent or vaccine against HPV in the near future, so it is important that, despite the difficulties, the currently available Godley, Bradbeer, Gellan, Thin methods are evaluated by further studies. 
